UniProt ID | AURKA_HUMAN | |
---|---|---|
UniProt AC | O14965 | |
Protein Name | Aurora kinase A | |
Gene Name | AURKA | |
Organism | Homo sapiens (Human). | |
Sequence Length | 403 | |
Subcellular Localization | Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Cytoplasm, cytoskeleton, spindle pole . Cytoplasm, cytoskeleton, cilium basal body . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole . Detected at the | |
Protein Description | Mitotic serine/threonine kinase that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Required for initial activation of CDK1 at centrosomes. Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity. Required for normal axon formation. Plays a role in microtubule remodeling during neurite extension. Important for microtubule formation and/or stabilization. Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and stabilizing p53/TP53. Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity. Necessary for proper cilia disassembly prior to mitosis.. | |
Protein Sequence | MDRSKENCISGPVKATAPVGGPKRVLVTQQFPCQNPLPVNSGQAQRVLCPSNSSQRVPLQAQKLVSSHKPVQNQKQKQLQATSVPHPVSRPLNNTQKSKQPLPSAPENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MDRSKENCISG ----CCCCCCCCCCC | 39.80 | 18691976 | |
5 | Ubiquitination | ---MDRSKENCISGP ---CCCCCCCCCCCC | 54.57 | 24816145 | |
10 | Phosphorylation | RSKENCISGPVKATA CCCCCCCCCCCEEEC | 38.96 | 16083426 | |
14 | Ubiquitination | NCISGPVKATAPVGG CCCCCCCEEECCCCC | 43.06 | 33845483 | |
16 | Phosphorylation | ISGPVKATAPVGGPK CCCCCEEECCCCCCC | 26.27 | 16083426 | |
23 | Ubiquitination | TAPVGGPKRVLVTQQ ECCCCCCCEEEEEEE | 59.41 | 29967540 | |
39 | Ubiquitination | PCQNPLPVNSGQAQR CCCCCCCCCCCCCCE | 13.51 | 24816145 | |
41 | Phosphorylation | QNPLPVNSGQAQRVL CCCCCCCCCCCCEEE | 32.30 | 16083426 | |
51 | Phosphorylation | AQRVLCPSNSSQRVP CCEEECCCCCCCCCC | 48.63 | 17895985 | |
53 | Phosphorylation | RVLCPSNSSQRVPLQ EEECCCCCCCCCCCH | 31.99 | 18691976 | |
54 | Phosphorylation | VLCPSNSSQRVPLQA EECCCCCCCCCCCHH | 26.68 | 29214152 | |
63 | Acetylation | RVPLQAQKLVSSHKP CCCCHHHHHHHCCCC | 54.60 | 26051181 | |
66 | Phosphorylation | LQAQKLVSSHKPVQN CHHHHHHHCCCCCCC | 36.84 | 18691976 | |
67 | Phosphorylation | QAQKLVSSHKPVQNQ HHHHHHHCCCCCCCH | 28.22 | 16083426 | |
69 | Ubiquitination | QKLVSSHKPVQNQKQ HHHHHCCCCCCCHHH | 49.16 | - | |
82 | Phosphorylation | KQKQLQATSVPHPVS HHHHHHHCCCCCCCC | 19.80 | 21406692 | |
83 | Phosphorylation | QKQLQATSVPHPVSR HHHHHHCCCCCCCCC | 36.35 | 16083426 | |
89 | Phosphorylation | TSVPHPVSRPLNNTQ CCCCCCCCCCCCCCC | 32.41 | 22451695 | |
95 | Phosphorylation | VSRPLNNTQKSKQPL CCCCCCCCCCCCCCC | 35.98 | 28555341 | |
98 | Phosphorylation | PLNNTQKSKQPLPSA CCCCCCCCCCCCCCC | 27.06 | 16083426 | |
99 | Ubiquitination | LNNTQKSKQPLPSAP CCCCCCCCCCCCCCC | 64.07 | 29967540 | |
104 | Phosphorylation | KSKQPLPSAPENNPE CCCCCCCCCCCCCHH | 65.23 | 16083426 | |
116 | Phosphorylation | NPEEELASKQKNEES CHHHHHHHHHCCHHH | 48.52 | 20068231 | |
117 | Ubiquitination | PEEELASKQKNEESK HHHHHHHHHCCHHHH | 60.73 | 29967540 | |
141 | Ubiquitination | EIGRPLGKGKFGNVY CCCCCCCCCCCCCEE | 67.61 | 32015554 | |
143 | Ubiquitination | GRPLGKGKFGNVYLA CCCCCCCCCCCEEEE | 54.29 | 27667366 | |
143 | Acetylation | GRPLGKGKFGNVYLA CCCCCCCCCCCEEEE | 54.29 | 25953088 | |
148 | Phosphorylation | KGKFGNVYLAREKQS CCCCCCEEEECHHHH | 9.92 | 17192257 | |
171 | Ubiquitination | LFKAQLEKAGVEHQL HHHHHHHHCCCCHHH | 60.06 | 33845483 | |
175 | Ubiquitination | QLEKAGVEHQLRREV HHHHCCCCHHHHHHH | 25.62 | 22817900 | |
177 | Ubiquitination | EKAGVEHQLRREVEI HHCCCCHHHHHHHHH | 24.14 | 27667366 | |
197 | Phosphorylation | HPNILRLYGYFHDAT CCCHHHHEEEECCCC | 11.89 | 22817900 | |
199 | Phosphorylation | NILRLYGYFHDATRV CHHHHEEEECCCCEE | 5.56 | 22817900 | |
212 | Phosphorylation | RVYLILEYAPLGTVY EEEEEEECCCHHHHH | 15.29 | 22817900 | |
226 | Phosphorylation | YRELQKLSKFDEQRT HHHHHHHHCCCHHHH | 38.01 | 16083426 | |
227 | Ubiquitination | RELQKLSKFDEQRTA HHHHHHHCCCHHHHH | 68.24 | 29967540 | |
250 | Ubiquitination | ALSYCHSKRVIHRDI HHHHHHCCCEECCCC | 27.33 | 21963094 | |
258 | Acetylation | RVIHRDIKPENLLLG CEECCCCCHHHEECC | 51.04 | 26051181 | |
258 | Sumoylation | RVIHRDIKPENLLLG CEECCCCCHHHEECC | 51.04 | 28112733 | |
258 | Ubiquitination | RVIHRDIKPENLLLG CEECCCCCHHHEECC | 51.04 | 22817900 | |
266 | Phosphorylation | PENLLLGSAGELKIA HHHEECCCCCEEEEE | 32.82 | 16083426 | |
278 | Phosphorylation | KIADFGWSVHAPSSR EEEECCEEEECCCCC | 12.38 | 16083426 | |
284 | Ubiquitination | WSVHAPSSRRTTLCG EEEECCCCCCCCCCC | 25.40 | 21963094 | |
284 | Phosphorylation | WSVHAPSSRRTTLCG EEEECCCCCCCCCCC | 25.40 | 16785988 | |
287 | Phosphorylation | HAPSSRRTTLCGTLD ECCCCCCCCCCCCCC | 24.02 | 19668197 | |
288 | Phosphorylation | APSSRRTTLCGTLDY CCCCCCCCCCCCCCC | 20.45 | 16785988 | |
292 | Ubiquitination | RRTTLCGTLDYLPPE CCCCCCCCCCCCCHH | 18.56 | 22817900 | |
292 | Phosphorylation | RRTTLCGTLDYLPPE CCCCCCCCCCCCCHH | 18.56 | 22322096 | |
295 | Phosphorylation | TLCGTLDYLPPEMIE CCCCCCCCCCHHHHC | 24.99 | 24732914 | |
342 | Phosphorylation | QETYKRISRVEFTFP HHHHHHHHCEEEECC | 34.02 | 16762494 | |
369 | Phosphorylation | RLLKHNPSQRPMLRE HHHHCCHHHCHHHHH | 44.10 | 17525332 | |
389 | Acetylation | WITANSSKPSNCQNK CCCCCCCCCCCCCCH | 52.89 | 26051181 | |
391 | Phosphorylation | TANSSKPSNCQNKES CCCCCCCCCCCCHHH | 54.71 | 16083426 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
10 | S | Phosphorylation | Kinase | AURKA | O14965 | PhosphoELM |
16 | T | Phosphorylation | Kinase | AURKA | O14965 | PhosphoELM |
41 | S | Phosphorylation | Kinase | AURKA | O14965 | PhosphoELM |
67 | S | Phosphorylation | Kinase | AURKA | O14965 | PhosphoELM |
83 | S | Phosphorylation | Kinase | AURKA | O14965 | PhosphoELM |
98 | S | Phosphorylation | Kinase | AURKA | O14965 | PhosphoELM |
104 | S | Phosphorylation | Kinase | AURKA | O14965 | PhosphoELM |
148 | Y | Phosphorylation | Kinase | AURKA | O14965 | GPS |
148 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
226 | S | Phosphorylation | Kinase | AURKA | O14965 | PhosphoELM |
266 | S | Phosphorylation | Kinase | AURKA | O14965 | PhosphoELM |
278 | S | Phosphorylation | Kinase | AURKA | O14965 | PhosphoELM |
287 | T | Phosphorylation | Kinase | AURKA | O14965 | PhosphoELM |
288 | T | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
288 | T | Phosphorylation | Kinase | AURKA | O14965 | PhosphoELM |
288 | T | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
288 | T | Phosphorylation | Kinase | PAK1 | Q13153 | PSP |
288 | T | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
288 | T | Phosphorylation | Kinase | CHUK | O15111 | GPS |
342 | S | Phosphorylation | Kinase | PAK1 | Q13153 | PSP |
342 | S | Phosphorylation | Kinase | PAK-SUBFAMILY | - | GPS |
342 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
342 | S | Phosphorylation | Kinase | AURKA | O14965 | PhosphoELM |
342 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
342 | S | Phosphorylation | Kinase | PAK | - | Uniprot |
391 | S | Phosphorylation | Kinase | AURKA | O14965 | PhosphoELM |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXL7 | Q9UJT9 | PMID:24658274 |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXW7 | Q969H0 | PMID:16863506 |
- | K | Ubiquitination | E3 ubiquitin ligase | CHFR | Q96EP1 | PMID:18335050 |
- | K | Ubiquitination | E3 ubiquitin ligase | FZR1 | Q9UM11 | PMID:12023018 |
- | K | Ubiquitination | E3 ubiquitin ligase | KLHL18 | O94889 | PMID:23213400 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AURKA_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-53, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41; SER-51 AND SER-83,AND MASS SPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-369, AND MASSSPECTROMETRY. | |
"Functional interaction of Aurora-A and PP2A during mitosis."; Horn V., Thelu J., Garcia A., Albiges-Rizo C., Block M.R., Viallet J.; Mol. Biol. Cell 18:1233-1241(2007). Cited for: SUBCELLULAR LOCATION, INTERACTION WITH PPP2CA, AND PHOSPHORYLATION ATSER-51. | |
"The GIT-associated kinase PAK targets to the centrosome and regulatesAurora-A."; Zhao Z.S., Lim J.P., Ng Y.W., Lim L., Manser E.; Mol. Cell 20:237-249(2005). Cited for: PHOSPHORYLATION AT THR-288 AND SER-342. | |
"Modulation of kinase-inhibitor interactions by auxiliary proteinbinding: crystallography studies on Aurora A interactions with VX-680and with TPX2."; Zhao B., Smallwood A., Yang J., Koretke K., Nurse K., Calamari A.,Kirkpatrick R.B., Lai Z.; Protein Sci. 17:1791-1797(2008). Cited for: X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 125-391 IN COMPLEX WITHVX-680 AND TPX2, PHOSPHORYLATION AT THR-288, MASS SPECTROMETRY, ANDSUBUNIT. | |
"Structural basis of Aurora-A activation by TPX2 at the mitoticspindle."; Bayliss R., Sardon T., Vernos I., Conti E.; Mol. Cell 12:851-862(2003). Cited for: X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 122-403 IN COMPLEX WITH TPX2,MUTAGENESIS OF ASP-274, ACTIVE SITE, AND PHOSPHORYLATION AT THR-287AND THR-288. | |
"An essential role of the aPKC-Aurora A-NDEL1 pathway in neuriteelongation by modulation of microtubule dynamics."; Mori D., Yamada M., Mimori-Kiyosue Y., Shirai Y., Suzuki A., Ohno S.,Saya H., Wynshaw-Boris A., Hirotsune S.; Nat. Cell Biol. 11:1057-1068(2009). Cited for: FUNCTION, INTERACTION WITH TPX2, PHOSPHORYLATION AT THR-287 ANDTHR-288, AND MUTAGENESIS OF THR287. | |
"BRCA1 phosphorylation by Aurora-A in the regulation of G2 to Mtransition."; Ouchi M., Fujiuchi N., Sasai K., Katayama H., Minamishima Y.A.,Ongusaha P.P., Deng C., Sen S., Lee S.W., Ouchi T.; J. Biol. Chem. 279:19643-19648(2004). Cited for: FUNCTION, INTERACTION WITH BRCA1, PHOSPHORYLATION AT THR-288, ANDMUTAGENESIS OF LYS-162. | |
"Aurora-A and an interacting activator, the LIM protein Ajuba, arerequired for mitotic commitment in human cells."; Hirota T., Kunitoku N., Sasayama T., Marumoto T., Zhang D., Nitta M.,Hatakeyama K., Saya H.; Cell 114:585-598(2003). Cited for: FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT THR-288. | |
"The mitotic serine/threonine kinase Aurora2/AIK is regulated byphosphorylation and degradation."; Walter A.O., Seghezzi W., Korver W., Sheung J., Lees E.; Oncogene 19:4906-4916(2000). Cited for: FUNCTION, PHOSPHORYLATION AT THR-288, MUTAGENESIS OF THR-288,UBIQUITINATION, AND ENZYME REGULATION. |